These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12879437)

  • 1. Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome.
    O'Malley DP; Whalen M; Banks PM
    Am J Hematol; 2003 Aug; 73(4):294-5. PubMed ID: 12879437
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
    Brown SL; Dale DC
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):341-3. PubMed ID: 9502302
    [No Abstract]   [Full Text] [Related]  

  • 3. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
    Veerappan R; Morrison M; Williams S; Variakojis D
    Bone Marrow Transplant; 2007 Aug; 40(4):361-4. PubMed ID: 17563733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
    Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
    Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid disease progression in two cases of myelodysplastic syndrome (MDS) following short therapy with G-CSF.
    Zomas A; Fisfis M; Stefanoudaki-Sofianatou K
    Haematologica; 1997; 82(2):253-4. PubMed ID: 9175335
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
    Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
    Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet syndrome associated with granulocyte colony-stimulating factor.
    Bidyasar S; Montoya M; Suleman K; Markowitz AB
    J Clin Oncol; 2008 Sep; 26(26):4355-6. PubMed ID: 18779624
    [No Abstract]   [Full Text] [Related]  

  • 8. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
    Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
    Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous splenic rupture in myelodysplastic syndrome.
    Raafat A; Mills MJ; Traub NE; Townend DM; Hoffbrand AV
    Eur J Haematol; 1989 Apr; 42(4):410-1. PubMed ID: 2721665
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atraumatic splenic rupture in patients with myelodysplastic syndromes: report of a case occurred during treatment with 5-azacitidine and review of the literature.
    Forghieri F; Morselli M; Leonardi G; Potenza L; Bonacorsi G; Coluccio V; Paolini A; Maccaferri M; Colaci E; Fantuzzi V; Bigliardi S; Zaldini P; Riva G; Barozzi P; Leonardi L; Rossi A; Marasca R; Narni F; Luppi M
    Leuk Res; 2012 Mar; 36(3):e52-6. PubMed ID: 22172466
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor.
    Giri N; Pitel PA; Green D; Alter BP
    Br J Haematol; 2007 Sep; 138(6):815-7. PubMed ID: 17760812
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
    Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
    Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms.
    Becherer K; Golda N; Feldman M; Diaz-Arias A; Caldwell C
    J Cutan Pathol; 2009 Sep; 36(9):1024-6. PubMed ID: 19674208
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
    Yoshida Y; Asano S; Hirashima K; Takaku F
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
    [No Abstract]   [Full Text] [Related]  

  • 20. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
    Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.